Web Desc
Cancer Pathophysiology: Integrating the Host and Tumor Environments
Organizer(s): Sheila A. Stewart, Sandra S. McAllister and Lisa M. Coussens
Date: March 28 - April 01, 2016
Location: Beaver Run Resort, Breckenridge, CO, USA
Sponsored by Incyte Corporation, Infinity Pharmaceuticals, Inc., Journal of Molecular Cell Biology (JMCB), Roche and TESARO, Inc.
Summary of Meeting:
The local and systemic tumor microenvironments (TME) play a pivotal role in all stages of cancer development, including initiation, malignant conversion and metastasis, as well as regulating how neoplastic cells respond to cytotoxic, targeted and immune-based therapies. Research over the last decade has revealed the incredible diversity and plasticity that constitute the TME. Thus, the focus of this meeting will be to bring together a wide breadth of experts who focus on the various aspects of the TME with the intent of creating a more complete picture of the potential therapeutic landscape. The unique feature of this meeting is its breadth of experts focused on both the systemic and local TME, who also recognize varied paracrine interactions with heterogeneous neoplastic cells. Presentations will focus on emerging studies to enable attendees access to senior investigators, as well as new investigators spanning the diversity of disciplines called “cancer biology.” In addition to invited speakers, time will be allotted for short oral presentations selected from submitted abstracts and three integrated poster sessions.
Scholarship Deadline: December 1 2015
Discounted Abstract Deadline: December 1 2015
Abstract Deadline: January 4 2016
Discounted Registration Deadline: January 28 2016
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Incyte CorporationInfinity Pharmaceuticals, Inc.Journal of Molecular Cell Biology (JMCB)RocheTESARO, Inc.
We gratefully acknowledge additional support for this conference from:
Educational grant from Celgene CorporationDon Whitley Scientific LimitedHypOxygen
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Genentech, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA200185-01
Funding for this conference was made possible (in part) by 1R13CA200185-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Monday, March 28 | 4:00PM - 8:00PM
Arrival and Registration
Room: Foyer


Monday, March 28 | 6:00PM - 8:00PM
Welcome Mixer
Room: Foyer
No registration fees are used to fund alcohol served at this function.

Tuesday, March 29 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Tuesday, March 29 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Peaks 4-5

Speaker 1 of 1
Douglas Hanahan, ISREC, Switzerland
Microenvironments, Metastasis and Therapeutic Targeting

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 1 of 11
* Lisa M. Coussens, Oregon Health & Science University, USA

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 2 of 11
Sandra S. McAllister, Brigham & Women's Hospital/Harvard Medical School, USA
Systemic Regulation of Breast Cancer Progression

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 3 of 11
Julio Aguirre-Ghiso, Icahn School of Medicine at Mount Sinai, USA
Regulation of Tumor Dormancy

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 4 of 11
Christine Chaffer, Whitehead Institute for Biomedical Research, Canada
Role of the Primary Tumor in Determining Metastatic Success

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 5 of 11
Serkan Kir, Dana-Farber Cancer Institute, USA
Short Talk: PTH-related Protein and Adipose Tissue Browning in Cancer Cachexia

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 6 of 11
Michael Bradley Burns, Loyola University Chicago, USA
Poster Teaser: Genomic Landscape of Colorectal Tumors Shapes the Microbiome of the Tumor Microenvironment

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 7 of 11
Anna Brichkina, Institute of Molecular and Cell Biology, Singapore
Poster Teaser: p38MAPK-Dependent Reprogramming of Tumour Microenvironment as a Target for Lung Cancer Treatment

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 8 of 11
Courtney B. Betts, Oregon Health and Science University, USA
Poster Teaser: Reproductive State Dependent Alterations in Mammary Dendritic Cells and a Potential Role for Collagen

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 9 of 11
Carmen Bergom, Medical College of Wisconsin, USA
Poster Teaser: Novel Tools for Mapping Determinants of Radiation Sensitivity
in the Tumor Microenvironment


Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 10 of 11
Amy E. Baek, University of Illinois at Urbana-Champaign, USA
Poster Teaser: Effects of the Cholesterol Metabolite 27- Hydroxychoesterol on Immune Cells and Metastasis

Tuesday, March 29 | 9:00AM - 11:30AM
The Tumor Systemic Environment I: Circulating Cells, Microve
sicles and Cytokines

Room: Peaks 4-5

Speaker 11 of 11
Liz C. Halvorsen, BC Cancer Agency, Canada
Poster Teaser: CCR5 Antagonists as Immune-Modulating Agents for the
Treatment of Breast Cancer Metastasis


Tuesday, March 29 | 9:40AM - 10:00AM
Coffee Break
Room: Foyer


Tuesday, March 29 | 11:30AM - 5:00PM
On Own for Lunch


Tuesday, March 29 | 11:30AM - 1:00PM
Poster Setup
Room: Peaks 1-3


Tuesday, March 29 | 1:00PM - 10:00PM
Poster Viewing
Room: Peaks 1-3


Tuesday, March 29 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Tuesday, March 29 | 5:00PM - 7:00PM
The Tumor Systemic Environment II: Processes that Promote Ca
ncer Progression

Room: Peaks 4-5

Speaker 1 of 5
* Sandra S. McAllister, Brigham & Women's Hospital/Harvard Medical School, USA

Tuesday, March 29 | 5:00PM - 7:00PM
The Tumor Systemic Environment II: Processes that Promote Ca
ncer Progression

Room: Peaks 4-5

Speaker 2 of 5
Pepper Jo Schedin, Oregon Health & Science University, USA
Weaning-Induced Tissue Remodeling, Metastasis and Young Women’s Breast Cancer

Tuesday, March 29 | 5:00PM - 7:00PM
The Tumor Systemic Environment II: Processes that Promote Ca
ncer Progression

Room: Peaks 4-5

Speaker 3 of 5
Derek Radisky, Mayo Clinic, USA
Epithelial and Stromal Alterations that Drive Breast Cancer Progression from Benign Breast Disease

Tuesday, March 29 | 5:00PM - 7:00PM
The Tumor Systemic Environment II: Processes that Promote Ca
ncer Progression

Room: Peaks 4-5

Speaker 4 of 5
Giorgio Trinchieri, NCI, National Institutes of Health, USA
Cancer as a Disease of the Symbiont/Metaorganism

Tuesday, March 29 | 5:00PM - 7:00PM
The Tumor Systemic Environment II: Processes that Promote Ca
ncer Progression

Room: Peaks 4-5

Speaker 5 of 5
Mauricio da Silva Caetano, University of Texas MD Anderson Cancer Center, USA
Short Talk: Gender –Specific Role of Epithelial STAT3 in K-Ras Mutant Lung Tumorigenesis

Tuesday, March 29 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Peaks 1-3
No registration fees are used to fund alcohol served at this function.

Tuesday, March 29 | 7:30PM - 10:00PM
Poster Session 1
Room: Peaks 1-3


Wednesday, March 30 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 1 of 12
* Judith A. Varner, University of California, San Diego, USA

Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 2 of 12
David G. DeNardo, Washington University Medical School, USA
Reprogramming the Tumor Microenvironment to Facilitate Responses to Immunotherapy.

Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 3 of 12
Mikala Egeblad, Cold Spring Harbor Laboratory, USA
Cancer Cell Expression of a Chemokine Receptor Promotes Immune Evasion

Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 4 of 12
Andy Minn, University of Pennsylvania, USA
Viral Mimicry in the Tumor Microenvironment Regulates Therapy Resistance

Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 5 of 12
Daniela F. Quail, McGill University, Canada
Deciphering Mechanisms of Resistance to Microenvironment-Targeted Therapies

Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 6 of 12
Lauren I. R. Ehrlich, University of Texas at Austin, USA
Short Talk: Endogenous Dendritic Cells from the Tumor Microenvironment
Directly Support T-ALL Growth through IGF1R Activation


Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 7 of 12
Sharon A. Glynn, National University of Ireland Galway, Ireland
Poster Teaser: Para-endocrine Interactions Between Prostate Cancer and
Bone Marrow Mesenchymal Stem Cells Enhance Tumour Cell Invasive Capacity and Proliferation


Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 8 of 12
Ryan S. Lane, Genentech, Inc., USA
Poster Teaser: Inducible PD-L1 expression on Lymphatic Endothelial Cells
in the Tumor Microenvironment


Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 9 of 12
Kevin C. Flanagan, Washington University in St. Louis, USA
Poster Teaser: c-Myb and C/EBPbeta Control Stromal-Derived Pro-Tumorigenic OPN Expression

Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 10 of 12
Nako Maishi, Hokkaido University, Japan
Poster Teaser: Tumor Endothelial Cells Promote Metastasis via Biglycan

Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 11 of 12
Ariel Munitz, Tel Aviv University, Israel
Poster Teaser: Eosinophils are an Integral Part of the Tumor Microenvironment Exerting Potent Anti-Tumorigenic Functions

Wednesday, March 30 | 8:00AM - 11:15AM
Immune Cells I: Adaptive and Innate Immune Cells in the TME
Room: Peaks 4-5

Speaker 12 of 12
Bhavna Murali, Washington University in St. Louis, USA
Poster Teaser: Inhibition of the Stromal p38MAPK Pathway Abrogates Breast
Cancer Metastases


Wednesday, March 30 | 9:20AM - 9:40AM
Coffee Break
Room: Foyer


Wednesday, March 30 | 11:15AM - 5:00PM
On Own for Lunch


Wednesday, March 30 | 11:15AM - 1:00PM
Poster Setup
Room: Peaks 1-3


Wednesday, March 30 | 1:00PM - 10:00PM
Poster Viewing
Room: Peaks 1-3


Wednesday, March 30 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Wednesday, March 30 | 5:00PM - 7:00PM
Immune Cells II: Immune Regulation of Cancer Progression
Room: Peaks 4-5

Speaker 1 of 5
* David G. DeNardo, Washington University Medical School, USA

Wednesday, March 30 | 5:00PM - 7:00PM
Immune Cells II: Immune Regulation of Cancer Progression
Room: Peaks 4-5

Speaker 2 of 5
Judith A. Varner, University of California, San Diego, USA
PI3Kgamma Signaling in Immune Cells and Cancer


Wednesday, March 30 | 5:00PM - 7:00PM
Immune Cells II: Immune Regulation of Cancer Progression
Room: Peaks 4-5

Speaker 3 of 5
Shannon J. Turley, Genentech, Inc., USA
Immunological Hallmarks of the Stromal Niche

Wednesday, March 30 | 5:00PM - 7:00PM
Immune Cells II: Immune Regulation of Cancer Progression
Room: Peaks 4-5

Speaker 4 of 5
Roberta Faccio, Washington University, USA
Dickkopf-Related Protein 1 (Dkk1) Exerts Immune Suppressive Effects in Cancer by Regulating Expansion and Function of Myeloid Derived Suppressor Cells

Wednesday, March 30 | 5:00PM - 7:00PM
Immune Cells II: Immune Regulation of Cancer Progression
Room: Peaks 4-5

Speaker 5 of 5
Yu Zhu, Washington University, USA
Short Talk: Pancreatic Tumor-Associated Macrophages Have Different
Origin and Functions


Wednesday, March 30 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Peaks 1-3
No registration fees are used to fund alcohol served at this function.

Wednesday, March 30 | 7:30PM - 10:00PM
Poster Session 2
Room: Peaks 1-3


Thursday, March 31 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 1 of 10
* Ittai Ben-Porath, Hebrew University of Jerusalem, Israel

Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 2 of 10
Sheila A. Stewart, Washington University School of Medicine, USA
Age-Related Changes in the Tumor Microenvironment Drive Increased Tumorigenesis

Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 3 of 10
Amanda Lund, New York University, USA
Lymphatic Vessels and Immune Regulation in the Tumor Microenvironment

Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 4 of 10
Arne Ostman, Karolinska Institutet, Sweden
PDGFR-Positive Fibroblasts and Pericytes: Impact on Tumor Progression and Treatment Response

Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 5 of 10
Zachary T. Schafer, University of Notre Dame, USA
The Regulation of Cancer Cell Death by Extracellular Matrix Attachment

Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 6 of 10
Katharine White, University of California, San Francisco, USA
Short Talk: Arginine to Histidine Mutations can Confer Adaptive pH Sensing and Are Enriched in a Subset of Cancers

Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 7 of 10
Jessica Olive, Harvard University, USA
Poster Teaser: Examining the Effects of the Systemic Environment on
Intratumoral Heterogeneity, Breast Cancer Progression and Therapeutic Resistance


Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 8 of 10
Camilla Salvagno, Netherlands Cancer Institute, Netherlands
Poster Teaser: Therapeutic Synergy Between Macrophage Blockade and
Chemotherapy in Breast Cancer Elicits Neutrophil-Dependent Therapy Resistance


Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 9 of 10
Honami Naora, University of Texas MD Anderson Cancer Center, USA
Poster Teaser: Transcriptional Dysregulation of Megakaryopoiesis and Erythropoiesis: Implications for the Tumor Microenvironment

Thursday, March 31 | 8:00AM - 11:15AM
Paracrine Signaling I: Primary Tumor Microenvironment
Room: Peaks 4-5

Speaker 10 of 10
Edward J. Richards, Massachusetts Institute of Technology, USA
Poster Teaser: TAM Family RTKs Promote the Metastatic Niche at the
Tumor-Immune Interface through Suppressing Cytokine Production in Residing Immune Cell Populations


Thursday, March 31 | 9:20AM - 9:40AM
Coffee Break
Room: Foyer


Thursday, March 31 | 11:15AM - 5:00PM
On Own for Lunch


Thursday, March 31 | 11:15AM - 1:00PM
Poster Setup
Room: Peaks 1-3


Thursday, March 31 | 1:00PM - 10:00PM
Poster Viewing
Room: Peaks 1-3


Thursday, March 31 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Thursday, March 31 | 5:00PM - 7:00PM
Paracrine Signaling II: Microenvironment at Metastatic Sites
Room: Peaks 4-5

Speaker 1 of 5
* Sheila A. Stewart, Washington University School of Medicine, USA

Thursday, March 31 | 5:00PM - 7:00PM
Paracrine Signaling II: Microenvironment at Metastatic Sites
Room: Peaks 4-5

Speaker 2 of 5
Mara H. Sherman, Oregon Health & Science University, USA
Stromal Regulation and Therapeutic Targeting of the Pancreatic Cancer Epigenome

Thursday, March 31 | 5:00PM - 7:00PM
Paracrine Signaling II: Microenvironment at Metastatic Sites
Room: Peaks 4-5

Speaker 3 of 5
Yuval Shaked, Technion - Israel Institute of Technology, Israel
Macrophage-Induced Lymphangiogenesis following Paclitaxel Chemotherapy Is Regulated by VEGFR3

Thursday, March 31 | 5:00PM - 7:00PM
Paracrine Signaling II: Microenvironment at Metastatic Sites
Room: Peaks 4-5

Speaker 4 of 5
Ittai Ben-Porath, Hebrew University of Jerusalem, Israel
Regulation of Transitions in Differentiation State in Basal-Like Breast Cancer

Thursday, March 31 | 5:00PM - 7:00PM
Paracrine Signaling II: Microenvironment at Metastatic Sites
Room: Peaks 4-5

Speaker 5 of 5
Mark A. Eckert, University of Chicago, USA
Short Talk: Compartment-Resolved Proteomics Reveals a Stromal Signature of Ovarian Cancer Metastasis

Thursday, March 31 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Peaks 1-3
No registration fees are used to fund alcohol served at this function.

Thursday, March 31 | 7:30PM - 10:00PM
Poster Session 3
Room: Peaks 1-3


Friday, April 01 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Friday, April 01 | 8:00AM - 11:00AM
Therapeutic Considerations I: Targeting the TME
Room: Peaks 4-5

Speaker 1 of 6
* Shahin Rafii, Weill Cornell Medical College, USA

Friday, April 01 | 8:00AM - 11:00AM
Therapeutic Considerations I: Targeting the TME
Room: Peaks 4-5

Speaker 2 of 6
Gabriele A.I. Bergers, University of Leuven, Belgium
Intertwined Functional Regulation of Angiogenesis, Invasion and Immune Modulation in Cancer

Friday, April 01 | 8:00AM - 11:00AM
Therapeutic Considerations I: Targeting the TME
Room: Peaks 4-5

Speaker 3 of 6
Robert S. Kerbel, Sunnybrook Research Institute, Canada
Impact of the Organ Microenvironment on the Response of Primary Tumors Versus Metastases to Antiangiogenic Therapy

Friday, April 01 | 8:00AM - 11:00AM
Therapeutic Considerations I: Targeting the TME
Room: Peaks 4-5

Speaker 4 of 6
Jennifer Ann Wargo, University of Texas MD Anderson Cancer Center, USA
Understanding the Heterogeneity and Dynamics of the Anti-Tumor Immune Response

Friday, April 01 | 8:00AM - 11:00AM
Therapeutic Considerations I: Targeting the TME
Room: Peaks 4-5

Speaker 5 of 6
Xinming Su, Washington University, USA
Short Talk: Integrin Beta3 Antagonism Increases Immune Suppression in Cancer

Friday, April 01 | 8:00AM - 11:00AM
Therapeutic Considerations I: Targeting the TME
Room: Peaks 4-5

Speaker 6 of 6
Lisa M. Coussens, Oregon Health & Science University, USA
Inflammation and Cancer: Immune Cells as Targets for Anti-Cancer Therapy

Friday, April 01 | 9:20AM - 9:40AM
Coffee Break
Room: Foyer


Friday, April 01 | 11:00AM - 5:00PM
On Own for Lunch


Friday, April 01 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Friday, April 01 | 5:00PM - 7:00PM
Therapeutic Considerations II: Targeting the Systemic Enviro
nment

Room: Peaks 4-5

Speaker 1 of 5
* Robert S. Kerbel, Sunnybrook Research Institute, Canada

Friday, April 01 | 5:00PM - 7:00PM
Therapeutic Considerations II: Targeting the Systemic Enviro
nment

Room: Peaks 4-5

Speaker 2 of 5
Shahin Rafii, Weill Cornell Medical College, USA
Maladapted Vascular Niche Initiates Tumor Invasion and Metastasis

Friday, April 01 | 5:00PM - 7:00PM
Therapeutic Considerations II: Targeting the Systemic Enviro
nment

Room: Peaks 4-5

Speaker 3 of 5
Seth B. Coffelt, University of Glasgow and Cancer Research UK, UK

Friday, April 01 | 5:00PM - 7:00PM
Therapeutic Considerations II: Targeting the Systemic Enviro
nment

Room: Peaks 4-5

Speaker 4 of 5
Kyoko Hida, Hokkaido University, Japan
Heterogeneity of Tumor Endothelial Cells

Friday, April 01 | 5:00PM - 7:00PM
Therapeutic Considerations II: Targeting the Systemic Enviro
nment

Room: Peaks 4-5

Speaker 5 of 5
Jessica Cedervall, Uppsala University, Sweden
Short Talk: Tumor-induced Neutrophil Extracellular Traps (NETs) -
Drivers of Systemic Inflammation and Organ Failure


Friday, April 01 | 7:00PM - 7:15PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Peaks 4-5


Friday, April 01 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Peaks 1-3
No registration fees are used to fund alcohol served at this function.

Friday, April 01 | 8:00PM - 11:00PM
Entertainment
Room: Peaks 1-3
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Friday, April 01 | 8:00PM - 11:00PM
Cash Bar
Room: Peaks 1-3


Saturday, April 02 | 10:25AM - 10:25AM
Departure


*Session Chair.